Medifast, Inc.
Market Cap
$110.46M
P/E Ratio
-5.91
EPS
$-1.70
Dividend Yield
0.00%
52-Week Range
$9.22 — $15.46
Volume
230.38K
Avg Volume
263.95K
Beta
0.58
P/E (TTM)
-5.91
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
0.27
P/B (TTM)
0.53
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.09%
ROA (TTM)
-0.07%
ROIC
—
Gross Margin
0.71%
Operating Margin
-0.04%
Net Margin
—
Debt/Equity
0.08
Current Ratio
4.69
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.45%
EPS Growth (5Y)
-0.09%
Sales Growth (3Y)
-0.24%
Sales Growth (5Y)
+0.04%
EPS Est (This Year)
$-1.61
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$15.22
Price Target Range
Consensus Target: $83.50(730.8% upside)
Institutional %
59.57%
Inst. Net Change
-188403
Insider Net Shares (90d)
—
Outstanding Shares
10.99M
Float
9.17M
Free Float %
83.40%
RSI (14)
42.61
SMA 20
$11.49
SMA 50
$11.35
SMA 200
$12.76
ATR (14)
0.50
Volatility (Week)
0.03%
Volatility (Month)
0.02%
Pattern
—
1 Day
-1.42%
1 Week
+1.18%
1 Month
-2.45%
3 Months
-6.62%
6 Months
-13.17%
1 Year
—
YTD
+7.12%
All-Time High
$16.66
Sector
Consumer Cyclical
Industry
Personal Products & Services
Country
US
Exchange
NYSE
IPO Date
1993-12-30
Employees
504
CEO
Daniel R. Chard
Index Membership
—
Website
https://medifastinc.com
Medifast, Inc. (MED) is a consumer cyclical company in the personal products & services industry listed on the NYSE. With a market capitalization of $110.46M, a P/E ratio of -5.91, MED is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MED against other stocks using dozens of fundamental and technical filters.
Medifast, Inc. (MED) has a trailing twelve-month (TTM) P/E ratio of -5.91. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Medifast, Inc. (MED) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Medifast, Inc. (MED) has a market capitalization of $110.46 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Medifast, Inc. (MED) has returned +7.12% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.